Beyond UCD, the company plans to initiate a phase 1b trial in patients with cirrhosis and hyperammonemia. In addition to SYNB1020, SYNB1618, a candidate probiotic to treat phenylketonuria (PKU ...

Sandra A. Banta-Wright, MN, RNC, NNP; Robert D. Steiner, MD Neonates with profound and prolonged hyperammonemia with coma due to urea cycle defect will have had a neurological insult to the brain ...